Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood

• Publication date

  2010-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2010-06-288068PMID 20668230PMCID PMC2981538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

  2009cited by this paper
• HIV gag protein is efficiently cross‐presented when targeted with an antibody towards the DEC‐205 receptor in Flt3 ligand‐mobilized murine DC

  2009cited by this paper
• Enhancing immune responses by targeting antigen to DC

  2009cited by this paper
• Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC‐205/CD205‐positive mouse dendritic cells

  2008cited by this paper
• DEC‐205/CD205+ dendritic cells are abundant in the white pulp of the human spleen, including the border region between the red and white pulp

  2008cited by this paper
• CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells1

  2008cited by this paper
• Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.

  2008cited by this paper
• The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

  2008cited by this paper
• A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivo

  2007cited by this paper
• Differential Antigen Processing by Dendritic Cell Subsets in Vivo

  2007cited by this paper
• DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

  2007cited by this paper
• Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine

  2006cited by this paper
• The C‐type lectin‐like domain superfamily

  2005cited by this paper
• Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Nonintegrin/CD209 Is Abundant on Macrophages in the Normal Human Lymph Node and Is Not Required for Dendritic Cell Stimulation of the Mixed Leukocyte Reaction1

  2005cited by this paper
• HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation.

  2004cited by this paper
• High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.

  2004cited by this paper
• In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination

  2004cited by this paper
• Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell Maturation

  2003cited by this paper
• Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance

  2002cited by this paper
• Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo

  2001cited by this paper
• A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells.

  2000cited by this paper
• The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing

  1995cited by this paper
• Antigen-specific human antibodies from mice comprising four distinct genetic modifications

  1994cited by this paper
• New Generation Vaccines

  1990cited by this paper

• A bioengineered antibody conjugate reshape dendritic cell viability for immune-tolerance modulation

  2025cites this paper
• Lymphatic distribution considerations for subunit vaccine design and development.

  2024cites this paper
• Lymph node targeting for immunotherapy

  2023cites this paper
• Identification of dendritic cell precursor from the CD11c+ cells expressing high levels of MHC class II molecules in the culture of bone marrow with FLT3 ligand

  2023cites this paper
• Antigen cross-presentation in dendric cells: From bench to bedside.

  2023cites this paper
• RHCG-Upregulating Polymeric Nanoparticles for Sensitized Chemotherapy and Immunotherapy in Head and Neck Squamous Cell Carcinoma

  2023cites this paper
• Targeting dendritic cells to advance cross-presentation and vaccination outcomes.

  2023cites this paper
• Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy

  2022cites this paper
• Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo

  2022cites this paper
• Author Correction: Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza

  2021cites this paper
• Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza

  2021cites this paper
• Characterization of a Nanovaccine Platform Based on an α1,2-Mannobiose Derivative Shows Species-non-specific Targeting to Human, Bovine, Mouse, and Teleost Fish Dendritic Cells.

  2021cites this paper
• Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy.

  2021cites this paper
• Targeting human langerin promotes HIV-1 specific humoral immune responses

  2021cites this paper
• Targeting Haemagglutinin Antigen of Avian Influenza Virus to Chicken Immune Cell Receptors Dec205 and CD11c Induces Differential Immune-Potentiating Responses

  2021cites this paper
• Ex vivo assessment of in vivo DC-targeted antibodies in pre-clinical models.

  2020cites this paper
• Metabolic labeling and targeted modulation of dendritic cells

  2020cites this paper
• Intradermal Delivery of Dendritic Cell-Targeting Chimeric mAbs Genetically Fused to Type 2 Dengue Virus Nonstructural Protein 1

  2020cites this paper
• Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead

  2020cites this paper
• Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting

  2020cites this paper
• Advancing immunomodulation by in vivo antigen delivery to DEC-205 and other cell surface molecules using recombinant chimeric antibodies.

  2019cites this paper
• Enhancing Antigen Cross-Presentation in Human Monocyte-Derived Dendritic Cells by Recruiting the Intracellular Fc Receptor TRIM21

  2019cites this paper
• Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine

  2019cites this paper
• Induction of a robust humoral response using HIV-1 VLPMPER-V3as a novel candidate vaccine in BALB/c mice.

  2019cites this paper
• (54) METHOD FOR IDENTIFYING SUBJECTS WITH AGGRESSIVE MELANOMA SKIN CANCER AT DIAGNOSIS VERFAHREN ZUR IDENTIFIZIERUNG VON SUBJEKTEN MIT AGGRESSIVEM MELANOM-HAUTKREBS BEI DER DIAGNOSE PROCÉDÉ POUR IDENTIFIER DES SUJETS ATTEINTS DE MÉLANOME AGRESSIF LORS D’UN DIAGNOSTIC DU CANCER DE LA PEAU

  2019cites this paper
• Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes

  2019cites this paper
• Construction and expression of a single-chain variable fragment antibody against chicken DEC 205 for targeting the bacterial expressed hemagglutinin-neuraminidase of Newcastle disease virus.

  2019cites this paper
• University of Birmingham Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas

  2019cites this paper
• A DNA Vaccine Encoding the Gn Ectodomain of Rift Valley Fever Virus Protects Mice via a Humoral Response Decreased by DEC205 Targeting

  2019cites this paper
• Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses

  2019cites this paper
• Heterologous prime-boost vaccination protects from EBV antigen expressing lymphomas.

  2019cites this paper
• The potential of nanoparticle vaccines as a treatment for cancer

  2018cites this paper
• Linking T cell epitopes to a common linear B cell epitope: A targeting and adjuvant strategy to improve T cell responses

  2018cites this paper
• Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis

  2018influential citation
• Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines

  2017cites this paper
• Using dendritic cell receptors to enhance immunity

  2017cites this paper
• Dendritic cell harmonised immunity to poultry pathogens; a review

  2017cites this paper
• Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine

  2017cites this paper
• Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.

  2017cites this paper
• Efficient priming of CD4 T cells by Langerin-expressing dendritic cells targeted with porcine epidemic diarrhea virus spike protein domains in pigs.

  2017cites this paper
• Old and new adjuvants.

  2017cites this paper
• In vivo targeting of protein antigens to dendritic cells using anti‐DEC‐205 single chain antibody improves HIV Gag specific CD4+ T cell responses protecting from airway challenge with recombinant vaccinia‐gag virus

  2017cites this paper
• Targeting of the WT191–138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination

  2017cites this paper
• Dendritic cell targeted HIV‐1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells

  2017cites this paper
• Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.

  2016cites this paper
• Genetically modified human CD4+ T cells can be evaluated in vivo without lethal graft‐versus‐host disease

  2016cites this paper
• A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice

  2016cites this paper
• Analysis of Intracellular Trafficking of Dendritic Cell Receptors for Antigen Targeting.

  2016cites this paper
• Antibody-Mediated Delivery of Antigen to Dendritic Cells

  2016cites this paper
• T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials

  2016cites this paper
• Dendritic cell-based immunotherapy

  2016cites this paper
• The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells

  2016cites this paper
• Exosomes : immunomodulators in cancer and therapy

  2016cites this paper
• A Dendritic cell targeted vaccine induces long term HIV-specific immunity within the gastrointestinal tract

  2016cites this paper
• Keratin mediates the recognition of apoptotic and necrotic cells through dendritic cell receptor DEC205/CD205

  2016cites this paper
• Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance

  2016cites this paper
• Aptamers: new arrows to target dendritic cells

  2016cites this paper
• Rational Design of Targeted Next-Generation Carriers for Drug and Vaccine Delivery.

  2016cites this paper
• ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.

  2016cites this paper
• Macrophages and Dendritic Cells: Partners in Atherogenesis.

  2016cites this paper
• pH-dependent recognition of apoptotic and necrotic cells by the human dendritic cell receptor DEC205

  2015cites this paper
• Dendritic Cell Targeting Vaccines

  2015cites this paper
• Novel HIV-1 Gag-specific Exosome-targeted CD8+ T cell-Based Therapeutic Vaccine Capable of Converting CTL Exhaustion in Chronic Infection

  2015cites this paper
• Vaccine adjuvant uses of poly-IC and derivatives

  2015cites this paper
• Enhanced Humoral Responses Induced by Targeting of Antigen to Murine Dendritic Cells

  2015cites this paper
• Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo

  2015cites this paper
• Manipulation of antigen presenting cells to enhance host immune responses to bacterial infection

  2015cites this paper
• Dendritic cells primed with protein-protein fusion adjuvant.

  2014cites this paper
• Targeting human dendritic cells in situ to improve vaccines.

  2014cites this paper
• Vaccine strategies utilizing C-type lectin receptors on dendritic cells in vivo

  2014influential citation
• Aptamer-targeted Antigen Delivery

  2014cites this paper
• Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine

  2014cites this paper
• Increased Generation of HIV-1 gp120-Reactive CD8+ T Cells by a DNA Vaccine Construct Encoding the Chemokine CCL3

  2014cites this paper
• Dhodapkar NY-ESO-1 to the Dendritic Cell Receptor DEC-205 Induction of Antigen-Specific Immunity with a Vaccine Targeting

  2014cites this paper
• HIV Vaccines: A Brief Overview

  2014cites this paper
• Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205

  2014cites this paper
• SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines

  2014cites this paper
• Recent advances and new opportunities for targeting human dendritic cells in situ

  2014cites this paper
• IMMUNE RESPONSES THAT CORRELATE WITH HIV-1 PROTECTION

  2014cites this paper
• Dendritic cell immunotherapy

  2013cites this paper
• Targeting the Non-structural Protein 1 from Dengue Virus to a Dendritic Cell Population Confers Protective Immunity to Lethal Virus Challenge

  2013cites this paper
• DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1.

  2013cites this paper
• Jianmin after antigen targeting to DEC-205 transformed B cells − Robust T-cell stimulation by Epstein-Barr virus

  2013cites this paper
• Tissue dendritic cells as portals for HIV entry

  2013cites this paper
• W Tissue dendritic cel

  2013cites this paper
• Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.

  2013cites this paper
• ALLERGEN DELIVERY TO DENDRITIC CELLS THROUGH DEC 205 EFFICIENTLY ELICITS SPECIFIC T CELL RESPONSES THAT ARE LIMITED BY THE PRESENCE OF VITAMIN D 3

  2013cites this paper
• Targeting of Autoantigens to DEC205+ Dendritic Cells In Vivo Suppresses Experimental Allergic Encephalomyelitis in Mice

  2013cites this paper
• Expression of Chicken DEC205 Reflects the Unique Structure and Function of the Avian Immune System

  2013cites this paper
• HIV impairment of immune responses in dendritic cells.

  2013cites this paper
• Dendritic cell dysregulation during HIV‐1 infection

  2013cites this paper
• Targeting antigen to bone marrow stromal cell‐2 expressed by conventional and plasmacytoid dendritic cells elicits efficient antigen presentation

  2013cites this paper
• Targeting Antigens to Dendritic Cell Receptors for Vaccine Development

  2013cites this paper
• Identification of target structures for new vaccines specifically directed at dendritic cells

  2013cites this paper
• Cross-presentation of IgG-containing immune complexes

  2013cites this paper
• DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8 + T cells independently of PD-1 and PD-L1

  2013cites this paper
• Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells

  2013cites this paper
• Decisions About Dendritic Cells : Past , Present , and Future

  2012influential citation
• Direcionando a proteína ASP-2 de formas amastigotas de Trypanosoma cruzi para o receptor DEC205 presente na superfície de células dendríticas.

  2012cites this paper
• Direcionando a proteína ASP-2 de formas amastigotas de Trypanosoma cruzi para o receptor DEC205 presente na superfície de células dendríticas

  2012cites this paper